Renaissance Technologies — VRTX Trade History
Quarter-by-quarter changes in the VERTEX PHARMACEUTICALS INC position · CUSIP 92532F100
Currently held · 6.8 YearsFirst seen: 2019 Q4
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Reduce | 320,008 | -101,680 | -24.1% | $159.0M | 0.22% |
| 2026 Q1 | 2026-05-14 | Reduce | 421,688 | -83,360 | -16.5% | $188.3M | 0.29% |
| 2025 Q4 | 2026-02-12 | Reduce | 505,048 | -230,840 | -31.4% | $229.0M | 0.35% |
| 2025 Q3 | 2025-11-13 | Reduce | 735,888 | -269,000 | -26.8% | $288.2M | 0.38% |
| 2025 Q2 | 2025-08-13 | Reduce | 1,004,888 | -166,683 | -14.2% | $447.4M | 0.59% |
| 2025 Q1 | 2025-05-14 | Reduce | 1,171,571 | -225,638 | -16.1% | $568.0M | 0.86% |
| 2024 Q4 | 2025-02-13 | Reduce | 1,397,209 | -234,284 | -14.4% | $562.7M | 0.83% |
| 2024 Q3 | 2024-11-13 | Add | 1,631,493 | 65,105 | +4.2% | $758.8M | 1.14% |
| 2024 Q2 | 2024-08-09 | Reduce | 1,566,388 | -14,100 | -0.9% | $734.2M | 1.25% |
| 2024 Q1 | 2024-05-13 | Reduce | 1,580,488 | -11,200 | -0.7% | $660.7K | 1.04% |
| 2023 Q4 | 2024-02-13 | Reduce | 1,591,688 | -72,400 | -4.4% | $647.6K | 1.00% |
| 2023 Q3 | 2023-11-14 | Add | 1,664,088 | 391,927 | +30.8% | $578.7K | 0.99% |
| 2023 Q2 | 2023-08-11 | Reduce | 1,272,161 | -125,574 | -9.0% | $447.7K | 0.65% |
| 2023 Q1 | 2023-05-12 | Reduce | 1,397,735 | -849,017 | -37.8% | $440.4K | 0.58% |
| 2022 Q4 | 2023-02-13 | Add | 2,246,752 | 107,867 | +5.0% | $648.8K | 0.89% |
| 2022 Q3 | 2022-11-14 | Add | 2,138,885 | 377,717 | +21.4% | $619.3M | 0.88% |
| 2022 Q2 | 2022-08-12 | Add | 1,761,168 | 53,800 | +3.2% | $496.3M | 0.59% |
| 2022 Q1 | 2022-05-13 | Add | 1,707,368 | 80,500 | +4.9% | $445.6M | 0.52% |
| 2021 Q4 | 2022-02-11 | Reduce | 1,626,868 | -264,618 | -14.0% | $357.3M | 0.44% |
| 2021 Q3 | 2021-11-12 | Reduce | 1,891,486 | -385,798 | -16.9% | $343.1M | 0.44% |
| 2021 Q2 | 2021-08-13 | Reduce | 2,277,284 | -123,000 | -5.1% | $459.2M | 0.57% |
| 2021 Q1 | 2021-05-13 | Reduce | 2,400,284 | -1,175,646 | -32.9% | $515.8M | 0.64% |
| 2020 Q4 | 2021-02-10 | Reduce | 3,575,930 | -1,631,002 | -31.3% | $845.1M | 0.92% |
| 2020 Q3 | 2020-11-13 | Reduce | 5,206,932 | -574,400 | -9.9% | $1.42B | 1.42% |
| 2020 Q2 | 2020-08-13 | Reduce | 5,781,332 | -1,078,350 | -15.7% | $1.68B | 1.45% |
| 2020 Q1 | 2020-05-14 | Reduce | 6,859,682 | -216,900 | -3.1% | $1.63B | 1.58% |
| 2019 Q4 | 2020-02-13 | New | 7,076,582 | 7,076,582 | — | $1.55B | 1.19% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.